Rk RH: Transposon Tc1 in the nematode Caenorhabditis elegans jumps in

Aus KletterWiki
Wechseln zu: Navigation, Suche

Mol Ther 2007. 208. Yant SR, Ehrhardt A, Mikkelsen JG, Meuse L, Pham T, Kay MA: Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nat Biotechnol 2002, 20:999?005. 209. Hausl M, Zhang W, Voigtlander R, Muther N, Rauschhuber C, Ehrhardt A: Improvement of adenovirus hybrid vectors for Sleeping Beauty transposition in substantial mammals. Curr Gene Ther 2011, 11:363?74. 210. Hausl MA, Zhang W, Muther N, Rauschhuber C, Franck HG, Merricks EP, Nichols TC, Kay MA, Ehrhardt A: Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B. Mol Ther 2010, 18:1896?906. 211. Bowers WJ, Mastrangelo MA, Howard DF, Southerland HA, Maguire-Zeiss KA, Federoff HJ: Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector. Mol Ther 2006, 13:580?88. 212. Zhang W, Solanki M, Muther N, Ebel M, Wang J, Sun C, Izsvak Z, Ehrhardt A: Hybrid adeno-associated viral vectors using transposase-mediated somatic integration for steady transgene expression in human cells. PLoS A single 2013, 8:e76771.213. Vink CA, Gaspar HB, Gabriel R, Schmidt M, McIvor RS, Thrasher AJ, Qasim W: Sleeping beauty transposition from nonintegrating lentivirus. Mol Ther 2009, 17:1197?204. 214. Galla M, Schambach A, Falk CS, Omipalisib Maetzig T, Kuehle J, Lange K, Zychlinski D, Heinz N, Brugman MH, Gohring G, et al: Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery. Nucleic Acids Res 2011, 39:7147?160. 215. Cai Y, Bak RO, Krogh LB, Staunstrup NH, Moldt B, Corydon TJ, Schr er LD, Mikkelsen JG: DNA transposition by protein transduction with the piggyBac transposase from lentiviral Gag precursors. Nucleic acids Res 2013. doi: 10.1093/nar/gkt1163. [Epub ahead of print].Rk RH: Transposon Tc1 from the nematode Caenorhabditis elegans jumps in human cells. Nucleic Acids Res 1998, 26:3013?017. 200. Ding S, Wu X, Li title= fpsyg.2016.00135 G, Han M, Zhuang Y, Xu T: Effective transposition of your piggyBac (PB) transposon in mammalian cells and mice. Cell 2005, 122:473?83. 201. Izsvak Z, Hackett PB, Cooper LJ, Ivics Z: Translating Sleeping Beauty transposition into cellular therapies: victories and challenges. Bioessays 2010, 32:756?67. 202. Ivics Z, Izsvak Z, Minter A, Hackett PB: Identification of functional domains and evolution of Tc1-like transposable components. Proc Natl Acad Sci USA 1996, 93:5008?013. 203. Yant SR, Park J, Huang Y, Mikkelsen JG, Kay MA: Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: vital residues for DNA binding and hyperactivity in mammalian cells. Mol Cell Biol 2004, 24:9239?247. 204. Staunstrup NH, Moldt B, Mates L, Villesen P, Jakobsen M, Ivics Z, Izsvak Z, Mikkelsen JG: Hybrid lentivirus-transposon vectors using a random integration profile in human cells. Mol Ther 2009, 17:1205?214. 205. Lacoste A, Berenshteyn F, Brivanlou AH: An effective and reversible transposable program for gene delivery and lineage-specific differentiation in human embryonic stem cells. Cell Stem Cell 2009, five:332?42. 206. Cadinanos J, Bradley A: Generation of an inducible and optimized piggyBac transposon program. Nucleic acids Res 2007, 35:e87. 207. Wilber A, Wangensteen KJ, Chen Y, Zhuo L, title= 02699931.2015.1049516 Frandsen JL, Bell JB, Chen ZJ, Ekker SC, McIvor RS, Wang X: Messenger RNA as a supply of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia kind I.